Side-by-side comparison of AI visibility scores, market position, and capabilities
Sports betting analytics platform with statistical models and matchup analysis; player props, injury news, and betting line tracking for recreational bettors in the expanding US sports wagering market.
Trendex is a sports betting and fantasy sports analytics platform providing statistical modeling, injury news, matchup analysis, and data-driven betting insights for recreational and serious sports bettors across football, basketball, baseball, and soccer — delivering content through a mobile app and website in the rapidly expanding US sports betting market following the 2018 PASPA Supreme Court ruling that legalized sports betting nationwide. Founded in 2021 and headquartered in the United States, Trendex targets sports fans who want data-driven edge in their sports betting and daily fantasy sports (DFS) decisions.\n\nTrendex aggregates player statistics, team performance metrics, injury reports, weather conditions, betting lines from major sportsbooks, and historical matchup data into predictive models that surface betting edges and player prop value for daily fantasy contests. The platform provides projected stats, injury probability, betting line movement analysis, and community picks from expert analysts. The mobile experience is designed for in-game consumption — checking player stats and injury news during live games.\n\nIn 2025, Trendex operates in the sports analytics and betting media market alongside established players like The Action Network (Chernin Group), DraftKings Rotogrinders, RotoWire, and ESPN Bet Insider for sports betting information. The US sports betting market has grown dramatically since legalization — approximately 30 states have legalized sports wagering — creating large consumer demand for actionable betting information. Trendex competes for user attention against free tools embedded in sportsbook apps (DraftKings, FanDuel, BetMGM all provide analytics within their apps) and established sports media brands. The 2025 strategy focuses on growing its subscriber base, adding more AI-powered predictive features, and expanding into additional sports leagues and international markets.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.